Safety Studies Leading to FDA Application for Stem Cell Therapy in SMA Will...
Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular...
View ArticleCalifornia Stem Cell, Inc. Concludes Series A Financing
Proceeds Fund Laboratory Build-Out, Pre-Clinical Development of Lead Therapeutic Candidates Irvine, CA – February 29, 2008 California Stem Cell, Inc. (CSC) has secured Series A financing from private...
View ArticleTherapeutic Approach Developed by CSC Scientific Advisory Board Members...
Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis Princeton, NJ – May 12, 2008 Medarex, Inc. (Nasdaq: MEDX) announced today that...
View ArticleCompanies Racing to Use Stem Cells to Find and Test New Drugs
New Technology Will Be Used To Help Discover Medicines Not Just To Repair Or Replace Damaged Cells Rob Waters (Bloomberg) – May 20, 2008 Two companies that produce different types of stem cells have...
View ArticleCalifornia Stem Cell and BioFocus DPI to Collaborate in ALS...
MOTORPLATE™ 96 Assay-Ready Well Plates Enable High Throughput and High Content Screening Assays Irvine, Calif – May 20, 2008 California Stem Cell, Inc. (CSC) today announced that it has signed a...
View ArticleHow Stem Cells Could Fight Lou Gehrig’s Disease
Forbes.com Special Report: Stem Cells Get Real Kerry A. Dolan and Robert Langreth – May 28, 2008 Patients with Lou Gehrig’s disease face a dismal prognosis. The only approved drug, Sanofi-Aventis’s...
View ArticleFirst Stem Cell Trials Might Start in O.C.
CSC could be the first to win federal approval for clinical trials. Colin Stewart / OC Register – June 25, 2008 A tiny start-up company in Irvine has a shot at becoming the first to gain federal...
View ArticleALS Therapy Development Institute and California Stem Cell, Inc. Announce...
Bi-coastal collaboration aimed at applying stem cell technology to an “orphan disease” in a unique translational research setting Cambridge, Mass. & Irvine, Calif – July 29, 2008 ALS Therapy...
View ArticleFamilies of Spinal Muscular Atrophy Funded Stem Cell Motor Neuron Replacement...
FSMA has invested $1.5 Million to develop a motor neuron replacement therapy for SMA, resulting in significant progress. Libertyville, Ill., December 30, 2008 FSMA has invested significant resources in...
View ArticleSpinal Cord Injury Treatment Invented and Co-Developed by CSC Scientific...
World’s first embryonic stem cell based treatment has received FDA clearance to begin clinical trial. MENLO PARK, Calif., January 23, 2009 Geron Corporation (Nasdaq: GERN) announced today that the U.S....
View ArticleFamilies of Spinal Muscular Atrophy and California Stem Cell Announce...
Funding Awarded from The Dhont Family Foundation to Families of Spinal Muscular Atrophy for $180,000 to Achieve Submission of Investigational New Drug (IND) Application to the FDA. Libertyville, Ill.,...
View ArticleTherapeutic Approach Developed by CSC Scientific Advisory Board Members...
Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis PRINCETON, N.J., May 14, 2009 Medarex, Inc. (Nasdaq: MEDX) today announced that the...
View ArticleCalifornia Stem Cell and Stemina Biomarker Discovery Announce Collaboration...
CardioPlate™ 96-well assay-ready plates enable predictive toxicology and high throughput screening assays. IRVINE, Calif. (September 17, 2009) Collaboration between California Stem Cell, Inc. (CSC) and...
View ArticleCalifornia Stem Cell, Inc. and Families of Spinal Muscular Atrophy Announce...
Significant Progress made Towards Moving Novel Therapy into Human Clinical Trials IRVINE, Calif. (October 14, 2009) California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA)...
View ArticleStem Cell Based Treatment for Spinal Muscular Atrophy Receives Orphan Drug...
California Stem Cell, Inc And Families Of Spinal Muscular Atrophy Reach Significant Milestone In Development Of Motor Neuron Treatment For SMA IRVINE, Calif. (December 7, 2009) California Stem Cell,...
View ArticleCalifornia Stem Cell, Inc. Closes Series B Financing Round
Investment to Enable Advancement of Therapeutic and Commercial Aims IRVINE, Calif. (December 21, 2009) California Stem Cell, Inc. (CSC), a leading stem cell company, announced that it has completed a...
View ArticleCalifornia Stem Cell and ALS Therapy Development Institute Extend Their...
Collaboration will further evaluate novel stem cell-derived product for the treatment of fatal neurodegenerative disease by regulating genes relevant to disease progression CAMBRIDGE, Mass. &...
View ArticleCalifornia Stem Cell SAB Chairman Hans Keirstead Wins 2010 Mathilde Solowey...
Prestigious award given for outstanding work in the field of neuroscience. IRVINE, Calif. (February 25, 2010) UC Irvine neurobiologist Hans S. Keirstead has been named the winner of the prestigious...
View ArticleCSC Scientist Receives Lloyd Guth Award For Excellence In Graduate Research...
Dr. Monica Siegenthaler lauded for her work in age-associated myelin pathogenesis and exercise attenuating functional deficits following spinal cord injury. IRVINE, Calif. (May 24, 2010) CSC Scientist...
View ArticleCSC Sab Members Hans S. Keirstead and Gabriel Nistor Create Retina From Human...
Complex tissue structure – a first – offers hope to millions with degenerative eye disorders IRVINE, Calif. (May 26, 2010) CSC Scientific Advisory Board members Hans S. Keirstead and Gabriel Nistor...
View Article